Precigen Inc
NASDAQ:PGEN
Precigen Inc
NASDAQ:PGEN
Price:
3.69
USD
-3.91%
Market Closed
Market Cap:
$1.3B
Relative Value
The Relative Value of one
PGEN
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 3.69 USD,
Precigen Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PGEN Relative Value
HIDDEN
Multiples Across Competitors
PGEN Competitors Multiples
Precigen Inc Competitors
Precigen Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Precigen Inc
NASDAQ:PGEN
|
1.3B USD | 206.9 | -3.1 | -12.2 | -11.9 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
397.3B USD | 6.7 | 169.2 | 16.4 | 23.2 | |
| US |
|
Astria Therapeutics Inc
NASDAQ:ATXS
|
326.4B USD | 462 374.5 | -2 631.9 | -2 389.6 | -2 389.6 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
203.9B USD | 5.6 | 26.5 | 15.1 | 15.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
178.6B USD | 6.1 | 21 | 14.2 | 14.2 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
121.7B USD | 10.1 | 30.7 | 23.5 | 24.5 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
81.1B USD | 5.7 | 18 | 13.5 | 15.4 | |
| AU |
|
CSL Ltd
ASX:CSL
|
70.7B AUD | 3.2 | 16.6 | 11.4 | 14.2 | |
| NL |
|
argenx SE
XBRU:ARGX
|
40.3B EUR | 13.2 | 31.1 | 52.8 | 54.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
